We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 54

Lundbeck v. Cobalt, Genpharm and Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 7 2009

The Court granted prohibition in respect of each of the proceedings against each defendant

Canada (Attorney General) v. Celgene Corporation, appeal of a PMPRB decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 20 2010

The Court of Appeal overturned the decision of the Trial Judge and restored the decision of the PMPRB providing jurisdiction to the PMPRB over medicines imported under the Special Access Program

Recent cases

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 21 2009

The Court granted an order of prohibition to Purdue in the face of Pharmascience’s allegations that the patent was invalid

Eli Lilly v. Hospira, interlocutory motion regarding further and better affidavit of documents

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • January 20 2010

In a case of patent infringement, the Case Management Prothonotary had ordered Hospira to produce a further and better Affidavit of Documents pursuant to an earlier motion by the Plaintiffs

Johnson & Johnson v. Boston Scientific

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

Johnson & Johnson (J&J) had sued Boston Scientific (Boston) for patent infringement

Biovail v. Apotex; merits of 55.2 proceeding; metformin

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

The Court dismissed the application for prohibition

Sanofi v. Hospira, merits of a 55.2 proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product

Apotex v. Pfizer

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 27 2009

The Court dismissed a motion by Pfizer for summary judgment in a s.8 proceeding

Law professor criticizes recent court rulings on patent disclosure

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 30 2009

In a recent issue of the Lawyers Weekly, Professor Jeremy de Beer of the University of Ottawa criticizes the uncertainty in Canadian patent law and calls on the Supreme Court to clarify disclosure obligations

Apotex v. Pfizer

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • March 4 2009

The Court of Appeal dismissed the generic company's appeal and upheld the decision of the trial judge prohibiting Apotex entering the market until the expiry of the patent